Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent Chronic Diseases: Depression Therapeutics, the first in a series on the current funding and R&D landscape for drugs to treat highly prevalent, chronic diseases.
January 18, 2018
· 3 min read